[Clinical studies on the new anticoagulant, marcoumar, and its antagonist, konakion (vitamin K1)].
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003374:Coumarins / Q000031:analogs & derivatives; D005260:Female; D005835:Genitalia; D005836:Genitalia, Female / Q000601:surgery*; D006801:Humans; D007020:Hypoprothrombinemias; D010644:Phenprocoumon; D049590:Postpartum Period / Q000150:complications*; D011516:Prothrombin; D013924:Thrombophlebitis / Q000628:therapy*; D014812:Vitamin K; D010837:Vitamin K 1
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003374:Coumarins; D014812:Vitamin K; D010837:Vitamin K 1; D011516:Prothrombin; C030123:coumarin; D010644:Phenprocoumon
COUMARIN/derivatives; GENITALIA, FEMALE/surgery; PROTHROMBIN/deficiency; PUERPERIUM/complications; THROMBOPHLEBITIS/therapy; VITAMIN K
Klinische Untersuchungen über das neue Antikoagulans Marcoumar [3-(1-Phenyl-propyl)-4-oxycumarin] und seinen Antagonisten Konakion (Vitamin K1).